Answers are grounded in this paper and cite their sources.
The efficacy of the antiviral R 61837 in experimental colds in three previously reported volunteer trials and one new trial is reviewed here. It was dissolved in a new vehicle, hydroxy-β-cyclodextrin, and used as a nasal spray. A substantial reduction in illness occurred when given prophylactically and during the incubation period but not when used therapeutically.
No takes yet. Share an insight, caveat, or question.
Barrow et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: